Dayan Victor, Soca Gerardo, Parma Gabriel, Mila Rafael
Department of Cardiac Surgery and Cardiology, Cardiovascular Center, Hospital de Clinicas, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay.
Interact Cardiovasc Thorac Surg. 2013 Jul;17(1):140-2. doi: 10.1093/icvts/ivt128.
A best evidence topic was written according to a structured protocol. Lack of evidence exists regarding the optimal timing for coronary artery bypass graft (CABG) surgery after non-ST myocardial infarction (NSTEMI). While some authors address the importance of the timing of surgery alone, others take into account the extent of myocardial damage. The question addressed was whether early or late CABG surgery improves hospital mortality and cardiovascular events after NSTEMI in stable patients. Using a designated search strategy, 459 articles were found, of which seven represented the best available evidence. All of these studies were level 3 (retrospective cohort studies). Studies could be divided into those which assessed CABG outcome based on preoperative cardiac troponin I (cTnI) level as a measure of the extent of myocardial damage and those which considered only the timing after myocardial infarction. Outcome measures included short-term survival, hospital mortality, length of hospital stay and major adverse cardiovascular events (MACEs). The biggest retrospective study analysing postoperative outcomes based on the timing of surgery after NSTEMI concluded that operative mortality is higher when surgery is performed within 6 h of the event. After 6 h, mortality is similar at any timepoint after 6h of NSTEMI. While other smaller studies agree that there are fewer postoperative complications when surgery is performed after 48 h of the event, no consensus is found regarding mortality between early (less than 48 h) and late CABG surgery. Taking into account preoperative cTnI values, CABG has a higher incidence of MACEs and hospital mortality in patients with cTnI >0.15 ng/ml. When surgery is performed within 24 h of symptoms, preoperative cTnI >0.72 ng/ml is associated with worse outcomes. In view of the methodological limitations and level of evidence of the studies included, it appears that surgery may be safely performed in NSTEMI patients at any time after the first 6 h of the event in patients with cTnI <0.15 ng/ml, whereas in those patients with higher values of cTnI, waiting for cTnI to reduce before considering surgery seems to be a wise option in order to decrease the incidence of MACEs and hospital mortality.
根据结构化方案撰写了一篇最佳证据主题。关于非ST段心肌梗死(NSTEMI)后冠状动脉旁路移植术(CABG)手术的最佳时机,目前缺乏证据。一些作者仅探讨了手术时机的重要性,而另一些作者则考虑了心肌损伤的程度。所探讨的问题是,早期或晚期CABG手术是否能改善稳定型NSTEMI患者的医院死亡率和心血管事件。通过指定的搜索策略,共找到459篇文章,其中7篇代表了最佳可用证据。所有这些研究均为3级(回顾性队列研究)。这些研究可分为两类,一类根据术前心肌肌钙蛋白I(cTnI)水平评估CABG结果,以此作为心肌损伤程度的衡量指标;另一类仅考虑心肌梗死后的时间。结果指标包括短期生存、医院死亡率、住院时间和主要不良心血管事件(MACE)。最大的一项回顾性研究分析了NSTEMI后手术时机与术后结果的关系,得出结论:在事件发生后6小时内进行手术,手术死亡率较高。在6小时后,NSTEMI发生6小时后的任何时间点死亡率相似。虽然其他较小规模的研究一致认为,在事件发生48小时后进行手术,术后并发症较少,但对于早期(小于48小时)和晚期CABG手术的死亡率,尚未达成共识。考虑术前cTnI值,cTnI>0.15 ng/ml的患者进行CABG时,MACE发生率和医院死亡率较高。当在症状出现后24小时内进行手术时,术前cTnI>0.72 ng/ml与更差的结果相关。鉴于所纳入研究的方法学局限性和证据水平,对于cTnI<0.15 ng/ml的患者,在事件发生的最初6小时后,似乎可以在任何时间安全地进行手术;而对于cTnI值较高的患者,为了降低MACE发生率和医院死亡率,在考虑手术前等待cTnI降低似乎是一个明智的选择。